Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
ArthroCare Corporation (NASDAQ: ARTC) shares gained 0.08 percent to close at $48.71 a share Tuesday. The stock traded between $48.30 and $48.75 on volume of 628,656 shares traded. Analysts at Craig-Hallum have recently downgraded the company’s rating to "hold" from "buy". Shares of ArthroCare have gained approximately 20.0 percent year-to-date.
Find out more about ArthroCare including full access to the free equity report at:
www.RDInvesting.com/ARTC
Cloud Peak Energy Inc. (NYSE: CLD) shares declined 3.97 percent to close at $18.15 a share Tuesday. The stock traded between $18.04 and $18.59 on volume of 1.76 million shares traded. Analysts at Iberia have recently downgraded the company’s rating to "sector perform" from "outperform". Shares of Cloud Peak Energy have gained approximately 1.0 percent year-to-date.
Find out more about Cloud Peak Energy including full access to the free equity report at:
www.RDInvesting.com/CLD
Equifax Inc. (NYSE: EFX)(TSX: EFX) shares increased 0.03 percent to close at $69.78 a share Tuesday. The stock traded between $68.60 and $69.92 on volume of 1.04 million shares traded. Analysts at Raymond James have recently downgraded the company’s rating to "market perform" from "outperform". Shares of Equifax have gained approximately 1.0 percent year-to-date.
Find out more about Equifax including full access to the free equity report at:
www.RDInvesting.com/EFX
Royal Gold, Inc. (NASDAQ: RGLD)(TSX: RGL) shares increased 0.76 percent to close at $67.32 a share Tuesday. The stock traded between $66.00 and $67.70 on volume of 1.17 million shares traded. Analysts at Raymond James have recently downgraded the company’s rating to "outperform" from "strong buy". Shares of Royal Gold have gained approximately 45.0 percent year-to-date.
Find out more about Royal Gold, including full access to the free equity report at:
www.RDInvesting.com/RGLD
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]